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Objective: Expression of inducible heme oxygenase has been shown to be increased
in various visceral inflammatory disorders, which may confer a protective role. The
purpose of our study was to determine whether the expression of inducible heme
oxygenase was up-regulated within lungs in a rat model of extracorporeal circula-
tion.
Methods: Wistar rats underwent either a partial femoro-femoral extracorporeal
circulation in normothermia for 3 hours (n  5) or a sham procedure (n  5).
Exhaled carbon monoxide concentration was monitored with an infrared analyzer.
After the rats were killed, lungs were harvested for determination of heme oxygen-
ase activity and inducible heme oxygenase expression (by Western blot and immu-
nohistochemistry). Lung injury was also assessed by arterial blood gas analysis and
microscopic study.
Results: Extracorporeal circulation was responsible for a lung injury characterized
by decreased arterial blood oxygen saturation and typical morphologic findings
(marked alveolar neutrophil infiltration; interstitial edema). Exhaled carbon mon-
oxide concentration remained stable throughout the experiment in all sham rats,
whereas it increased after extracorporeal circulation (from 0.16  0.05 ppm at
baseline to 0.7  0.2 ppm at end of experiment; P  .0001). Pulmonary heme
oxygenase activity and inducible heme oxygenase content (assessed by Western
blot) were increased within lungs of rats that underwent extracorporeal circulation.
Immunohistochemistry revealed that the expression of inducible heme oxygenase
was mainly localized to inflammatory cells.
Conclusions: Post–extracorporeal circulation acute lung injury in rats was associ-
ated with an increased expression of inducible heme oxygenase, the functional
significance of which remains to be determined.
Acute lung injury (ALI) is a potential complication of cardiacsurgery with extracorporeal circulation (ECC). The most severeforms are clinically easily recognizable with a reported incidenceof 0.5% to 1.7% and a mortality rate ranging from 50% to91.6%.1,2 However, in morphologic studies, ALI appeared toaffect most, if not all, patients shortly after cardiac surgery.3,4
Because there is no method available to detect and monitor the pulmonary inflam-
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matory insult noninvasively, the impact of milder forms of
postperfusion ALI on the postoperative morbidity and mor-
tality remains unknown.
Carbon monoxide is synthesized in mammalians, mainly
from heme degradation.5 Endogenously produced CO does
not accumulate within the body and is excreted in exhaled
breath.6 Heme oxygenase (HO) is the step-limiting enzyme
from heme catabolism. Three isoforms of HO have been
described, 1 inducible (HO1) and 2 constitutive (HO2 and
HO3). These isoforms differ by their cellular location and
the regulation of their expression.7 HO1 isoform has been
shown to be primarily induced during oxidative injury.8
Increased expression of HO1 has also been described in a
few experimental models of ALI, which was associated with
a protective role.9
The primary purpose of this study was to determine the
influence of extracorporeal circulation on the expression of
HO1 in postperfusion ALI by using a previously described
rat model of partial bypass.10 We also evaluated the impact
of extracorporeal circulation on the endogenous CO produc-
tion by measuring blood carboxyhemoglobin concentration
and monitoring exhaled CO concentration.
Materials and Methods
The study was approved by the local Institutional Animal Care and
Use Committee and all animals were treated according to the
European regulations for animal experimentation.11
Extracorporeal Circulation
Circuit preparation. The ECC circuit consisted of a nonpul-
satile roller pump (Jouvelet, Simal, Paris, France) and sterile
Tygon tubing with an inner diameter of 2.4 mm for the venous line
and 0.8 mm for the arterial line (Masterflex R3603, Bioblock
Scientific, Illkirch, France). ECC was established at a flow rate of
100 mL/kg/min. Venous return was drained by gravity into a
20-mL sterile reservoir. The membrane oxygenator obtained from
Capiox 308 (Terumo, Osaka, Japan) is commonly used in pediatric
cardiac surgery. To reduce the prime volume of the oxygenator
(110 mL), we removed the heat exchanger and placed at each
extremity of the membrane 2 silicone “cones” specifically de-
signed for the experiment. These cones excluded approximately
75% of the total membrane surface area from circulation. The total
prime volume of the circuit was 35 mL of which the oxygenator
constituted 15 mL. The priming was done with 20 mL of fresh
blood obtained from 2 homologous donor rats and with 15 mL of
synthetic colloid (Plasmion, Fre´se´nius, France). Gas flow (100%
O2) was maintained between 50 and 75 mL/min. Preliminary
experiments have shown that this gas flow was sufficient to
achieve adequate oxygenation.10
Surgical procedure. Male Wistar rats (475-550 g) were used
for all experiments. They were anesthetized with an intramuscular
administration of ketamine hydrochloride (80 mg/kg) and chlor-
promazine hydrochloride (2 mg/kg). Anesthesia was maintained
throughout the experiment with additional doses of intravenous
ketamine. Sustained muscle relaxation was achieved with an in-
travenous injection of 1 mg/kg of pancuronium bromide. Rats were
continuously ventilated through a tracheostomy with air at 80
breaths/min and 8 mL/kg tidal volume under 4 cm H2O positive
end-expiratory pressure (Harvard Rodent Respirator, model 680,
SARL Ealing, Ulis, France). Central temperature was monitored
with an esophageal probe and maintained between 36°C and 38°C
by a heating lamp placed above the animal and the oxygenator.
The tail artery was cannulated (25-gauge Teflon catheter; Ethicon,
Issy les Moulineaux, France) to monitor systemic arterial pressure
(Hewlett Packard, model 78342A; Hewlett Packard Company,
Palo Alto, Calif). The right femoral vein and artery were exposed
and cannulated with 16- and 25-gauge Teflon heparinized cathe-
ters, respectively. Anticoagulation consisted of heparin (500 IU/
kg), which was administered in the following manner: half the
dosage was given to the blood donor rats and a quarter of the
dosage was added to the priming volume and to the study rat.
Protocol
Rats were assigned to either an ECC group or a sham group. Both
the ECC and sham groups consisted of 5 rats. Anesthesia, venti-
lation, cannulation, and heparinization were identical in both
groups throughout the experiment. Connection to the extracorpo-
real circuit was only performed in the ECC group. Ventilation was
not discontinued during the ECC period. ECC lasted for 3 hours
and rats were further monitored for another 3 hours before they
were killed. After cessation of the ECC, rats were infused with the
remaining priming medium when diastolic pressure was less than
50 mm Hg. Arterial blood gas analysis was performed before the
start of ECC (baseline) and at the end of the experiment.
Rats were killed by exsanguination. They were then perfused
with 500 mL of cold saline (4°C). Lungs were harvested without
the trachea and the proximal bronchi. The left lung was immersed
in 4% neutral buffered formalin for 48 hours. The right lung was
homogenized in a buffer containing 50 mmol/L Tris-HCl (pH 7.4),
250 mmol/L sucrose, and 1 tablet (per 50 mL) of an antiprotease
mixture (Complete; Boehringer Mannheim, Meylan, France). The
homogenate was centrifuged at 10,000g for 20 minutes and the
supernatant was collected and stored at 80°C. Protein concen-
tration was determined by the modified Peterson method.
Measurement of Exhaled Carbon Monoxide
Concentration
Exhaled CO was measured using an infrared CO analyzer (CO
2000; Se´re`s, La Duranne, France). The CO analyzer was calibrated
prior to each experiment with a CO calibration gas at a concen-
tration of 10.3 ppm (Air Liquide, Bonneuil, France). Its sensitivity
was 0.1 ppm and its sampling rate was set at 1L/min.
All rats were ventilated with CO-free rendered air (CO con-
centration  0.1 ppm) by its passage through a heated hopcalite
filter (Se´re`s). Expired breath was collected into a 6-L polyethylene
bag that did not react with CO. The bag was placed at the
expiratory outlet of the ventilator and was rapidly connected to the
CO analyzer when filled. Each gas collection lasted approximately
20 minutes. Therefore, measurements indicated at each time point
represent the mean exhaled CO concentration of gas collected over
the preceding 20 minutes. Exhaled CO concentration was deter-
mined before (baseline), during (30, 90, and 180 minutes), and
after cessation (1, 2, and 3 hours) of ECC.
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Heme Oxygenase Activity
The method was derived from Tenhunen and colleagues.12 Briefly,
as a source of biliverdin reductase, livers from fasted rats were
harvested and immediately placed in cold 0.9% NaCL. The livers
were then weighed and homogenized in 4 volumes of 2 mmol/L
MgCl2–100 mmol/L phosphate buffer (pH 7.4). The homogenate
was centrifuged at 105,000g for 1 hour at 4°C and the supernatant
(liver cytosol) was used as a source of biliverdin reductase.
The reaction mixture consisted of 200 L of lung supernatant,
50 L of liver cytosol, 20 L of 1 mmol/L heme b solution, 200
L of 2.75 mmol/L -nicotinamide adenine dinucleotide phos-
phate (NADPH) solution, and 530 L of 2 mmol/L MgCl2–100
mmol/L phosphate buffer (pH 7.4). The samples were incubated in
a 37°C water bath in the dark for 1 hour. The reaction was stopped
by placement on ice. An NADPH-free reaction mixture provided a
baseline against which the measured concentrations were com-
pared. The absorbance of the samples was measured by spectro-
photometry (model DU-70; Beckman, Villepinte, France) at 464
and 530 nm. The amount of bilirubin formed was calculated from
the difference in optical density at 464 and 530 nm, assuming an
extinction coefficient of 40 mmol/L1 · cm1. The values are
expressed as picomoles of bilirubin formed per milligram of pro-
tein per hour.
HO1 Detection by Western Blot
An aliquot of homogenate was suspended in sodium dodecylsul-
phate (SDS) sample buffer (125 mmol/L Tris-HCl [pH  7.4],
10% glycerol, 6% SDS, 0.01% -mercaptoethanol, and 0.1%
bromophenol blue). Equal amounts of protein per lane (150 g)
were subjected to electrophoresis in a 12% SDS-polyacrylamide
gel. Gels were transferred onto nitrocellulose membranes by elec-
troblotting. The membranes were blocked by incubation in phos-
phate-buffered saline solution (PBS) 1X, 5% nonfat dry milk, and
0.2% Tween 20 for 1 hour at room temperature. Blots were then
incubated overnight at 4°C in the same buffer containing a rabbit
polyclonal antibody against rat HO1 (1:1,000; Tebu, France). Blots
were washed 4 times for 15 minutes in PBS 1X and 0.2% Tween
20 and thereafter incubated with horseradish peroxidase-conju-
gated goat anti-rabbit immunoglobulin G (IgG) secondary anti-
body (1:15,000; Amersham, Orsay, France). Blots were then
washed and immunoreactivity was assessed using an enhanced
Western blot detection system according to the manufacturer’s
protocol (Amersham). Spleen homogenates were used as positive
controls for HO1.
Histology
After fixation, the left lung was embedded in paraffin. Two sec-
tions of 3-m thickness were obtained from each block and stained
with hematoxylin-eosin.
Immunohistochemistry
Tissue sections were deparaffinized in xylene and then rehydrated
in graded alcohol solutions. The sections were blocked in a solu-
tion of 5% nonfat milk, 1% bovine serum albumin (BSA) before
incubation overnight at 4°C with a rabbit polyclonal antibody to
HO1 (Tebu, Le Perray, France) in 1% milk and 1% BSA in PBS
1X (1:1,000 dilution). The sections were washed 3 times with PBS
for 5 minutes each and incubated for 1 hour with secondary
antibody (biotinylated goat anti-mouse IgG; Jackson Laboratories,
L’arbresle, France) at a dilution of 1:500 in 1% milk, PBS 1X at
room temperature. The signal was detected with peroxidase-con-
jugated avidin and diaminobenzidine. The slides were counter-
stained with 1% hematoxylin. For negative controls, sections were
processed as above except that the primary incubation was per-
formed with nonimmune rabbit serum (Jackson Laboratories) in-
stead of primary antibody.
Blood Gas Analysis
Arterial blood gas analysis, pH, hematocrit, and carboxyhemoglo-
bin were determined with a calibrated blood gas analyzer (ABL
505; Radiometer, Copenhagen, Denmark) and a CO oximeter
(OSM 3, Radiometer).
Determination of Bilirubin and Hemoglobin Plasmatic
Concentration
Measurement of total bilirubin plasmatic concentration was per-
formed by using an automated colorimetric method (Synchron
CX7; Beckman Coulter, Villepinte, France). Hemoglobin concen-
tration was assessed spectrophotometrically by measuring the ab-
sorbance of the samples at 561 and 576 nm (DU70, Beckman
Coulter).
Statistics
Results are expressed as mean  standard deviation. Comparisons
of continuous data between sham and ECC groups were performed
with the Mann-Whitney test.
Results
All rats completed the study. Baseline mean arterial blood
pressure was 122  18 mm Hg in the sham group and 118
 10 mm Hg in the ECC group (P  .8288). Mean arterial
blood pressure remained stable throughout the experiment
and did not differ between the 2 groups at any time (data not
shown).
There was no difference in baseline arterial blood gas
values between ECC and sham groups (Table 1). ECC was
associated with a significant decrease in arterial oxygen-
ation (SaO2  80.8%  11.9% in the ECC group vs SaO2 
95.5%  3.7% in the sham group at the end of the exper-
iment; P  .009).
Histologically, rats from the ECC group had pulmonary
lesions consisting of interstitial edema and large areas of
marked intravascular, interstitial, and intra-alveolar neutro-
phil and macrophage infiltration (Figure 1). There were also
areas of alveolar hemorrhage. Conversely, only scattered
and rare neutrophils were found within the lungs in the
sham rats (Figure 1).
Baseline exhaled CO concentration was 0.14  0.05
ppm in the sham group and 0.16  0.05 ppm in the ECC
group (P  .5485). Exhaled CO concentration remained
stable throughout the experiment in sham rats (Figure 2). In
the ECC group, exhaled CO concentration started to in-
crease between 90 and 180 minutes of ECC. Three hours
after ECC discontinuation, exhaled CO concentration
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reached a peak value that was significantly higher than
baseline value (0.7  0.2 ppm at end of experiment vs 0.16
 0.05 ppm at baseline; P  .0001).
Blood carboxyhemoglobin concentration was not signif-
icantly different between the 2 experimental groups at base-
line and at end of experiment (Table 1). However, the
variation of carboxyhemoglobin concentration (end of ex-
periment concentration minus baseline concentration) was
significantly higher in the ECC group (0.46%  0.25% in
the ECC group vs 0.06%  0.11% in the sham group; P 
.0144). Bilirubin concentration was significantly lower in
the sham group at the end of experiment (6.6 1.3 mmol/L
in the sham group vs 16.8  3.4 mmol/L in the ECC group;
P  .0086). Free hemoglobin concentration at the end of
experiment was also significantly lower in the sham group
(Table 1).
HO activity was significantly higher in the rat lungs from
the ECC group (485  64.3 pmol/mg protein/h in the ECC
group vs 178.8  29.1 pmol/mg protein/h in the sham
group; P  .009). Likewise, there was a statistically signif-
icant difference between the 2 groups regarding the spleen
HO activity (Figure 3).
Western blot analysis revealed an increased HO1 protein
content within lungs of the rats from the ECC group with
respect to those from the sham group (Figure 4). Immuno-
histochemical studies revealed a marked expression of HO1
in neutrophils and macrophages infiltrating the rat lungs of
the ECC group. A mild expression of HO1 was sometimes
observed in airway epithelial cells. Conversely, no staining
was found in the rat lungs from the sham group (Figure 5).
Discussion
In this study, we demonstrated that a 3-hour ECC in rats was
responsible for an ALI. This inflammatory condition was
associated with an increase in HO1 expression and CO
concentration.
Based on the histological study (Figure 1), ECC in rats
was clearly responsible for a diffuse inflammatory disorder
of the lungs, which resembles the lung injury of other
models of ALI. Moreover, the morphological findings in
this rat model of post-ECC ALI were close to those previ-
ously described in larger animals (pig, dog, sheep) and in
humans.3,4 In a previous study, we also observed an in-
crease in lung water content (reflecting pulmonary edema)
and in Evans blue dye content (an index of microvascular
permeability) in lungs of rats that underwent a 90-minute
ECC.13
We chose to cannulate the femoral vessels to prevent the
lung injury that might have occurred with a thoracic ap-
proach. Our rat model of ECC was a partial bypass, with a
pump flow approximately equivalent to half of the theoret-
ical rat cardiac output. Ventilation, therefore, could not be
discontinued during ECC. Rats that underwent ECC sur-
vived without any evident sequela.10 We believe that our rat
model of partial bypass is appropriate to investigate the
pathophysiology and the natural course of postperfusion
ALI.
Carbon monoxide in the body originates from an endog-
enous source and an exogenous source. Ambient CO rep-
resents the exogenous source. Mammalian cells synthesize
CO (mainly from heme catabolism), which represents the
endogenous source.6 Endogenously produced CO does not
accumulate within the body. A small amount of CO is
oxidatively transformed into carbon dioxide at a rate of
0.1% to 0.2% of the CO body content per hour. The bulk of
synthesized CO is transported by blood (as carboxyhemo-
globin) to the lungs where it is excreted in exhaled breath.
Lung excretion is considered as the quasi-exclusive way of
CO elimination from the body. This pulmonary excretion
depends on many variables such as alveolar ventilation, CO
lung diffusing capacity, lung capillary oxygen partial pres-
sure, carboxyhemoglobin concentration, and endogenous
CO production.14
In the present study, we demonstrated for the first time an
increase in exhaled CO concentration after ECC. The con-
comitant increase in carboxyhemoglobin concentration (the
largest CO store within the body) suggests that the increased
exhaled CO reflects an increased endogenous CO produc-
tion. Systemic hemolysis is known to increase the endoge-
nous CO production and the exhaled CO concentration.15,16
Hemolysis occurred in our rat model of bypass (Table 1). In
TABLE 1. Biological study of post– extracorporeal circula-
tion (ECC) acute lung injury in rats
Sham (n  5) ECC (n  5) P value
Blood gas analysis
Baseline
PaO2 (mm Hg) 88 17.5 85.2 12.6 .9168
SaO2 (%) 95.1 4.1 95 3.2 .9168
PCO2 (mm Hg) 36.6 7.2 40.4 4.9 .3472
pH 7.45 0.45 7.45 0.49 .9999
Ht (%) 43.4 2.1 41.6 4.2 .5271
HbCO (%) 1.78 0.15 1.86 0.3 .4592
End of experiment
PaO2 (mm Hg) 95.6 11.3 73.2 13.8 .0361
SaO2 (%) 95.5 3.7 80.8 11.9 .009
PCO2 (mm Hg) 37.4 5.4 38.4 4.4 .6742
pH 7.45 0.1 7.39 0.05 .1745
Ht (%) 41.4 3.2 41.2 1.8 .9147
HbCO (%) 1.84 0.15 2.34 0.56 .2031
Bilirubin concentration
(mol/L)
6.6 1.3 16.8 3.4 .0086
Free hemoglobin
concentration (mg/L)
151.8 30.2 341.2 295.5 .0278
149.7 (130-205)* 274.3 (152-864)*
HbCO, Carboxyhemoglobin.
*Median (range).
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addition to hemolysis, other processes may explain the
increased endogenous CO production during ECC, such as
an exaggerated turnover of hemoproteins other than hemo-
globin (such as cytochromes, peroxidases) or the production
of CO secondary to lipid peroxidation.5
Elevated CO concentrations in exhaled breath have re-
cently been reported in various bronchopulmonary inflam-
matory disorders such as asthma,17 bronchiectasis,18 or cys-
tic fibrosis.19 This increased exhaled CO has been
demonstrated to reflect the severity of the inflammatory
process in some instances.17 We are not aware of any study
dealing with exhaled CO measurement in experimental or
clinical ALI. Based on our study, it seems unlikely that
monitoring exhaled CO will help noninvasive assessment of
the severity of the inflammatory process in postperfusion
ALI, as long as hemolysis persists.
In a recent study, we observed an increased heme oxy-
genase activity in lungs from rats that underwent a 90-
Figure 1. (Left) Acute lung injury in a rat that underwent a 3-hour extracorporeal circulation. Numerous macro-
phages and neutrophils infiltrating the interstitium and the alveolar spaces are visible. Stain: hematoxylin-eosin;
original magnification  400. (Right) Histology of a sham rat’s normal lung. Stain: hematoxylin-eosin; original
magnification  400.
Figure 2. Comparative evolution of the increase in exhaled carbon monoxide (CO) concentration of rats that
underwent a 3-hour extracorporeal circulation (ECC) (closed circles) compared with rats that did not (open
circles). Exhaled CO concentration remained unchanged in the sham group whereas it significantly increased in
the ECC group.
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minute ECC.13 In the present study, we demonstrated an
elevated HO1 isoform expression in postperfusion lung
injury. Up-regulation of HO1 within lungs has been previ-
ously reported in other models of ALI such as those fol-
lowing endotoxemia or prolonged hyperoxia.9,20 Increases
in HO1 mRNA and protein content have been detected
within lungs 2 to 4 hours and 4 to 8 hours after systemic
administration of endotoxin (a condition mimicking sepsis),
respectively. Immunohistochemical studies have shown that
up-regulation of HO1 occurred in various cells including air-
way epithelial cells or inflammatory cells. Similar findings
have been previously reported in hyperoxic lung injury20 and
were also observed in our rat model of post-ECC ALI.
In our rat model of bypass, the pulmonary up-regulation
of HO1 in post-ECC ALI was likely the consequence of
multiple factors. In vitro and in vivo studies have demon-
strated that cellular expression of HO1 can be dramatically
induced by hemoglobin.21 Up-regulation of HO1 could re-
flect, at least in part, the exposure of pulmonary cells to free
hemoglobin. Free hemoglobin might have originated from
Figure 3. Comparison of heme oxygenase activity in lung (left panel) and spleen homogenates (right panel) from
sham rats (closed bar) and rats that underwent a 3-hour extracorporeal circulation (open bar).
Figure 4. Representative Western blotting products of HO1 detection in lung homogenates of rats that underwent
either a 3-hour extracorporeal circulation (lanes 1, 2, and 3) or a sham procedure (lanes 5 and 6). Spleen
homogenates (lane 4) were used as positive controls.
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peripheral hemolysis, a well-known complication of pro-
longed bypass with roller pump as in our rat model, and
from intrapulmonary hemorrhage, a common microscopic
feature of post-ECC ALI.3,4 The blood concentrations of
various cytokines have also been shown to increase during
and after ECC.22 Recently, Kotani and colleagues23 re-
ported elevated concentrations of tumor necrosis factor,
interleukin 6, and interleukin 8 in patients’ bronchoalveolar
lavage fluid obtained after ECC. Thus, the systemic and
pulmonary production of proinflammatory cytokines might
also be responsible for the up-regulation of HO1 in post-
ECC ALI.7
There is a large growing body of evidence suggesting
that induction of HO1 expression may confer protection to
cells and tissues against oxidative injury. Recently, Yamada
and colleagues24 observed that up-regulation of HO1 (by
hemin or interleukin 1-) prevented the hydrogen peroxide–
induced increase in permeability of human tracheal epithe-
lium in culture. This protective effect was abolished by
competitive inhibitors of HO. Otterbein and associates25
also reported that overexpression of HO1 achieved by gene
transfer in rat lungs improved survival and attenuated the
lung injury secondary to prolonged hyperoxia. The func-
tional significance of HO1 up-regulation in post-ECC acute
lung injury is the subject of an ongoing experimental study
in our laboratory.
It has been speculated that the protection conferred by
HO1 up-regulation could be related to the byproducts of
heme degradation. Bilirubin has potent antioxidant proper-
ties in vitro.26 Hayashi and colleagues27 described a biliru-
bin-induced inhibition of neutrophil adhesion to the endo-
thelium during an oxidative vascular injury. Ferritin, the
synthesis of which can be induced by an HO-dependent iron
release,28 has also been demonstrated to be a potent antiox-
idant.29 Finally, CO (usually considered as a potentially
toxic waste product of metabolism) has been shown to have
a major anti-inflammatory action. Otterbein and cowork-
ers30 recently demonstrated that exogenous CO at low con-
centration (50-500 ppm) attenuated posthyperoxia ALI by
stimulation of the p38-mitogen–activated protein kinase
pathway. Fujita and colleagues31 also reported a protective
effect of CO in ischemia-reperfusion lung injury through
derepression of fibrinolysis. The role of the increased en-
dogenous CO production that we observed in our rat model
of bypass should be investigated.
In summary, we demonstrated that a 3-hour ECC in rats
was responsible for an ALI, which was associated with an
increased expression of HO1. We also observed an increase
Figure 5. Immunohistochemistry of lung sections. Pulmonary HO1 expression was not detected in sham rats (A).
In rats from the extracorporeal circulation group, no staining was observed in lung specimens not exposed to the
primary antibody (B). Neutrophils and macrophages (C and D) as well as some bronchiolar epithelial cells (D) were
stained positive for HO1 in rats that underwent a 3-hour extracorporeal circulation. Original magnification  1000.
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in exhaled CO concentration, reflecting an elevated endog-
enous CO production, possibly secondary to an exaggerated
hemolysis. The determination of the physiological signifi-
cance of the increased HO1 expression in lungs following
ECC will require further studies.
We are grateful to Professor Gilles Chatelier for his statistical
reviewing and to Sophie Goyer for her technical assistance.
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